BNP Paribas Financial Markets’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.4M Buy
528,889
+190,598
+56% +$13M 0.01% 857
2026
Q1
$21.9M Sell
338,291
-295,238
-47% -$20.8M 0.01% 1095
2025
Q4
$42.6M Sell
633,529
-143,457
-18% -$9.65M 0.02% 764
2025
Q3
$57M Buy
776,986
+508,555
+189% +$33.8M 0.03% 574
2025
Q2
$14M Sell
268,431
-174,326
-39% -$9.92M 0.01% 1222
2025
Q1
$28.3M Buy
442,757
+372,413
+529% +$21.6M 0.02% 869
2024
Q4
$3.36M Buy
70,344
+28,849
+70% +$1.48M ﹤0.01% 2044
2024
Q3
$2.38M Sell
41,495
-87,651
-68% -$5.02M ﹤0.01% 1955
2024
Q2
$6.76M Sell
129,146
-167,694
-56% -$7.35M 0.01% 1269
2024
Q1
$12.1M Buy
296,840
+76,129
+34% +$2.85M 0.01% 1003
2023
Q4
$8.16M Sell
220,711
-89,965
-29% -$3.39M 0.01% 1128
2023
Q3
$11.9M Buy
310,676
+72,422
+30% +$2.97M 0.02% 827
2023
Q2
$8.59M Buy
238,254
+133,057
+126% +$4.54M 0.01% 972
2023
Q1
$4.02M Sell
105,197
-106,111
-50% -$4.98M 0.01% 1376
2022
Q4
$12M Buy
211,308
+57,397
+37% +$2.94M 0.02% 882
2022
Q3
$6.09M Buy
153,911
+94,066
+157% +$4.16M 0.01% 1262
2022
Q2
$2.63M Buy
59,845
+14,454
+32% +$625K ﹤0.01% 1594
2022
Q1
$1.81M Sell
45,391
-9,160
-17% -$326K ﹤0.01% 1895
2021
Q4
$2.19M Sell
54,551
-44,371
-45% -$1.66M ﹤0.01% 1948
2021
Q3
$4.02M Buy
98,922
+4,410
+5% +$184K 0.01% 1431
2021
Q2
$4.29M Sell
94,512
-16,321
-15% -$722K 0.01% 1372
2021
Q1
$4.62M Sell
110,833
-57,891
-34% -$2.64M 0.01% 1213
2020
Q4
$7.21M Sell
168,724
-3,695
-2% -$133K 0.01% 947
2020
Q3
$4.53M Buy
172,419
+18,446
+12% +$514K 0.01% 1137
2020
Q2
$4.13M Sell
153,973
-399,692
-72% -$9.02M 0.01% 1133
2020
Q1
$9.96M Buy
553,665
+96,932
+21% +$1.84M 0.02% 671
2019
Q4
$8.1M Buy
456,733
+430,815
+1,662% +$7.46M 0.01% 963
2019
Q3
$402K Buy
25,918
+9,136
+54% +$150K ﹤0.01% 2332
2019
Q2
$288K Sell
16,782
-12,152
-42% -$196K ﹤0.01% 2368
2019
Q1
$466K Buy
28,934
+1,449
+5% +$23.5K ﹤0.01% 2139
2018
Q4
$402K Buy
27,485
+11,189
+69% +$178K ﹤0.01% 1879
2018
Q3
$296K Sell
16,296
-5,400
-25% -$94.6K ﹤0.01% 2237
2018
Q2
$366K Sell
21,696
-14,091
-39% -$266K ﹤0.01% 2144
2018
Q1
$701K Buy
35,787
+11,173
+45% +$216K ﹤0.01% 1974
2017
Q4
$499K Buy
24,614
+10,228
+71% +$188K ﹤0.01% 2476
2017
Q3
$250K Sell
14,386
-2,661
-16% -$36K ﹤0.01% 2352
2017
Q2
$219K Buy
17,047
+14,677
+619% +$196K ﹤0.01% 2396
2017
Q1
$30.7K Sell
2,370
-5,463
-70% -$69.1K ﹤0.01% 2901
2016
Q4
$77.4K Sell
7,833
-1,218
-13% -$13.3K ﹤0.01% 2641
2016
Q3
$109K Buy
9,051
+4,815
+114% +$49.2K ﹤0.01% 2057
2016
Q2
$36.6K Buy
+4,236
New +$41.8K ﹤0.01% 2399
2016
Q1
Sell
-22,106
Closed -$383K 2837
2015
Q4
$383K Sell
22,106
-15,241
-41% -$243K ﹤0.01% 1518
2015
Q3
$502K Buy
37,347
+21,023
+129% +$422K ﹤0.01% 1359
2015
Q2
$369K Buy
16,324
+6,352
+64% +$112K ﹤0.01% 1453
2015
Q1
$142K Buy
+9,972
New +$144K ﹤0.01% 1649
2014
Q4
Sell
-6,374
Closed -$58K 2507
2014
Q3
$58K Sell
6,374
-23,568
-79% -$224K ﹤0.01% 2504
2014
Q2
$296K Buy
+29,942
New +$254K ﹤0.01% 1690
2014
Q1
Sell
-1,152
Closed -$17.3K 3571
2013
Q4
$17.3K Sell
1,152
-23,080
-95% -$297K ﹤0.01% 2310
2013
Q3
$268K Sell
24,232
-6,185
-20% -$51.5K ﹤0.01% 2022
2013
Q2
$242K Buy
+30,417
New +$194K ﹤0.01% 2178

Other funds holding HALO

BNP Paribas Financial Markets's HALO Position: Q2 2026 in Review

BNP Paribas Financial Markets increased its Halozyme (HALO) stake by 56% in Q2 2026, buying an estimated $13M and bringing the position to 528,889 shares worth $41.4M. The position accounts for 0.01% of the portfolio, ranked #857.

BNP Paribas Financial Markets first reported a position in HALO in Q2 2013 and has held it in 50 quarters since. The position peaked at $57M in Q3 2025. 593 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • BNP Paribas Financial Markets held 528,889 shares of Halozyme worth $41.4M as of Q2 2026.
  • BNP Paribas Financial Markets bought 190,598 Halozyme shares in Q2 2026, an estimated $13M.
  • Halozyme made up 0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #857 holding.
  • BNP Paribas Financial Markets first reported a position in Halozyme in Q2 2013 and has held it in 50 quarters since.
  • BNP Paribas Financial Markets's Halozyme position peaked at $57M in Q3 2025.
  • 593 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.